Excelsior Correspondent
JAMMU, Apr 18: Council for Scientific and Industrial Research (CSIR) has launched BGR-34–country’s first anti-diabetic ayurvedic drug with DPP4 inhibitory activity.
BGR-34, designed for type 2 Diabetes mellitus has been scientifically validated for its efficacy and safety. BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP)–the research units of CSIR, Government of India situated at Lucknow.
Passing its larger benefits to people, BGR-34 has been economically priced at Rs 5 per tablet as compared to latest DPP4 inhibitors globally. BGR-34 is now available on all major chemist counters of Punjab, Haryana, Chandigarh and adjoining States of HP and J&K.
Dr AKS Rawat, Senior Principal Scientist, CSIR-NBRI said that “6 crore of the adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet. We are sure that eminent medical professionals will recommend it to their patients suffering from type 2 Diabetes mellitus for quicker and consistent response. CSIR’s premier research institutions have developed and established the efficacy of BGR-34. The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs”.
Formulation of this drug is a result of a novel joint research from the NBRI and CIMAP, the research units of Council of Scientific and Industrial Research (CSIR), Govt of India for the comprehensive, effective and safe management of type-II diabetes with a difference, he added.
KK Sharma, Managing Director of AIMIL Pharmaceuticals, said “We have decided to launch this marvellous anti-diabetic product in the brand name BGR-34, standing for Blood Glucose Regulator with 34 identified active phyto-constitutents from herbal resources. With a strong marketing distribution network spread all over the country, AIMIL is strongly committed to carry forward the marvellous benefits of this novel research to the suffering masses all throughout the country and abroad”.
Follow our WhatsApp channel
